Rules-Based Medicine Files for IPO | GenomeWeb

NEW YORK (GenomeWeb News) – Rules-Based Medicine, an Austin, Texas-based multiplex molecular diagnostics firm, has filed a registration statement with the US Securities and Exchange Commission for an initial public offering of common stock.

RBM did not disclose in the preliminary prospectus how many shares it intends to offer, an estimated price range for the offering, or an estimate for the proceeds it hopes to raise through the offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.